SecBot SecBot
3 ·Filed Nov 12, 2026

MTRI

InMed Pharmaceuticals Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed4d 11h ago SEC0001193125-26-458259
Actionable Insight • Neutral

These filings confirm the completion of a reverse merger where InMed Pharmaceuticals became the public parent of Mentari Therapeutics. Monitor future filings for the combined entity's operating results and any additional insider transactions that may signal confidence or concern.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1
Entry
$18.60
T+0 close · Nov 12, 2026 · via day close
Latest settled
+6.83%
T+1 · $19.87
Vs SPY
+8.74%
α at T+1
Next horizon
T+5
in 3d
  1. T+0 · Nov 13 $18.60entry
  2. T+1 · 20h ago +6.83%α +8.74% · $19.87
  3. T+5 · in 3d Pending
  4. T+20 · in 27d Pending
  5. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Three Form 3 filings were filed by new insiders (Laura Sandler, Michelle Pernice, Julianne Bruno) of Mentari Therapeutics, Inc. (formerly InMed Pharmaceuticals Inc.), each accompanied by a power of attorney. The filings disclose shares received in a merger that closed on November 6, 2026, where InMed Pharmaceuticals (the issuer) acquired Pre-Merger Mentari via a two-step merger. Pernice received 27,868 shares (19,740 restricted), Bruno received 33,442 shares (23,689 restricted), and Sandler's holdings are not stated. These are routine initial ownership filings following a reverse merger and do not convey new material information about the company's operations or financials.

Key Facts

  • Three Form 3 filings were filed on November 12, 2026, for the period ending November 6, 2026.
  • The filings relate to a merger effective November 6, 2026, where InMed Pharmaceuticals Inc. (issuer) acquired Pre-Merger Mentari Therapeutics via a two-step merger.
  • Michelle Pernice received 27,868 shares of common stock (19,740 restricted, vesting through August 2029) in exchange for Pre-Merger Mentari shares at a ratio of 0.20065.
  • Julianne Bruno received 33,442 shares of common stock (23,689 restricted, vesting through August 2029) in exchange for Pre-Merger Mentari shares at a ratio of 0.20065.
  • Laura Sandler's share count is not disclosed in the filing.
  • Each filing includes a power of attorney authorizing Jerad Seurer, Brett Hagen, Ryan Murr, and Branden Berns to file Forms 3, 4, and 5 on behalf of the reporting person.

Financial Impact

No financial impact from these filings; they are administrative ownership disclosures following a merger.

Risk Factors

  • No material risks identified from these routine filings.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (8 analysts)

Investment Themes

Documents Analyzed

This report is based on 12 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (MTRI), Batch item 10001193125-26-458259
Document: 0001193125-26-458259-index-headers.html0001193125-26-458258
Document: 0001193125-26-458259-index.html0001193125-26-458257
Document: 0001193125-26-458259.txt0001193125-26-458259
3 Filing (MTRI), Batch item 50001193125-26-458258
Document: 0001193125-26-458258-index-headers.html0001193125-26-458259
Document: 0001193125-26-458258-index.html0001193125-26-458259
Document: 0001193125-26-458258.txt0001193125-26-458259
3 Filing (MTRI), Batch item 90001193125-26-458257
Document: 0001193125-26-458257-index-headers.html0001193125-26-458259
Document: 0001193125-26-458257-index.html0001193125-26-458259
Document: 0001193125-26-458257.txt0001193125-26-458259

US Market Status

Market Closed · Opens in 6h 20m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 12, 2026